首页> 外文期刊>Autoimmunity reviews >Enhanced type I interferon gene signature in primary antiphospholipid syndrome: Association with earlier disease onset and preeclampsia
【24h】

Enhanced type I interferon gene signature in primary antiphospholipid syndrome: Association with earlier disease onset and preeclampsia

机译:原发性抗磷脂综合征中增强I型干扰素基因签名:与早期疾病发作和预胰岛素的关联

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: Recently, two studies demonstrated that a relevant percentage of primary antiphospholipid syndrome (PAPS) patients had an upregulation of interferon (IFN) genes. However, 20%-28% of these patients had anti-dsDNA, a highly specific systemic lupus erythematosus (SLE) autoantibody. This study aimed to determine the prevalence of the type I IFN signature in the peripheral blood mononuclear cells of PAPS patients without specific SLE autoantibodies and search for its clinical associations.
机译:目的:近日,两项研究表明,初级抗磷脂综合征(PAPS)患者的相关百分比具有对干扰素(IFN)基因的上调。 然而,20%-28%的这些患者具有抗DSDNA,一种高度特异性的全身性红斑狼疮(SLE)自身抗体。 本研究旨在确定在没有特定SLA自身抗体的PAPS患者的外周血单核细胞中I IFN签名的患病率,并寻找其临床关联。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号